Engineering Controls Within HPAPI Manufacturing
By Olindo Lazzaro, Director, Global EHS Technical Operations, & Max Brescia, Global Drug Product Account Director, AbbVie
As the demand in the global market for HPAPI drugs grows, so too is the expense of manufacturing HPAPIs due to the requirements for specialized facilities, additional PPE, medical surveillance for workers, pollution controls, and specialized housekeeping. As a result, more and more often the question pharmaceutical companies find themselves asking is, "Should we be searching for a CMO to manufacture our HPAPI?"
In this article, scientists from AbbVie Contract Manufacturing, a division of AbbVie, answer that question and discuss the strict regulations regarding the manufacture of HPAPIs and adherence to stringent guidelines to ensure that safety remains of paramount importance.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.